AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 FEB 14 - (NewsRx.com & NewsRx.net) --
- by Michelle Marble, staff medical writer -- According to a study from England, a major secreted mycobacterial antigen (Ag) may have potential as a candidate vaccine against tuberculosis.
"The role of CD8(+) cytotoxic T lymphocytes (CTL) in protection against tuberculosis in human disease is unclear," stated S.M. Smith and colleagues, University of London. "In this study, we stimulated the peripheral blood mononuclear cells of bacillus Calmette-Guerin (BCG)-vaccinated individuals with live Mycobacterium bovis BCG bacilli to establish short-term cell lines and then purified the CD8(+) T cells."
Smith et al. published the results of their study in the Journal of Immunology ("Human CD8(+) CTL specific for the mycobacterial major secreted antigen 85A," J Immunol, 2000;165(12):7088-7095).
"A highly sensitive enzyme-linked immunospot (ELISPOT) assay for single cell interferon (IFN)-gamma release was used to screen CD8(+) T cells with overlapping peptides spanning the mycobacterial major secreted protein, Ag85A," continued the researchers. "Three peptides consistently induced a high frequency of IFN-gamma responsive CD8(+) T cells, and two human leukocyte antigen (HLA)-A*0201 binding motifs, P48-56 and P242-250, were revealed within the core sequences."
The researchers isolated CD8(+) T cells which responded to the 9-mer epitopes by using ELISPOT within fresh blood using free peptide or by binding of HLA-A*0201 ...